Oxycodone

Generic Name
Oxycodone
Brand Names
Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
Drug Type
Small Molecule
Chemical Formula
C18H21NO4
CAS Number
76-42-6
Unique Ingredient Identifier
CD35PMG570
Background

Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...

Indication

Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.

Associated Conditions
Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
Associated Therapies
-

Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain

First Posted Date
2009-07-17
Last Posted Date
2017-02-27
Lead Sponsor
BioDelivery Sciences International
Target Recruit Count
153
Registration Number
NCT00941304
Locations
🇺🇸

Donald P. Bandy, DDS, San Marcos, Texas, United States

🇺🇸

Premier Research Group Limited, Salt Lake City, Utah, United States

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

First Posted Date
2009-06-10
Last Posted Date
2014-01-09
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Target Recruit Count
320
Registration Number
NCT00916890
Locations
🇮🇹

Servizio di Anestesia e Rianimazione e Terapia Antalgica - Ospedale Sant'Orsola-Poliambulanza, Brescia, Italy

🇮🇹

Servizio di Anestesia e Rianimazione e Terapia Antalgica - Ospedale Mellino Mellini, Chiari, Italy

🇮🇹

Struttura Complessa di Medicina Interna - Ospedale Civile di Voghera - Azienda Ospedaliera provincia di Pavia, Voghera, Pavia, Italy

and more 3 locations

Single Dose Pharmacokinetics of Egalet® Oxycodone

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-12-04
Last Posted Date
2016-08-29
Lead Sponsor
Egalet Ltd
Target Recruit Count
16
Registration Number
NCT00801788

Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-11-04
Last Posted Date
2012-07-09
Lead Sponsor
Katja venborg Pedersen
Target Recruit Count
55
Registration Number
NCT00784472
Locations
🇩🇰

Hospital Little Belt, Fredericia, Fredericia, Denmark

A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb

First Posted Date
2008-08-29
Last Posted Date
2018-12-04
Lead Sponsor
Pfizer
Target Recruit Count
36
Registration Number
NCT00743587
Locations
🇧🇪

Pfizer Investigational Site, Bruxelles, Belgium

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

First Posted Date
2008-08-01
Last Posted Date
2020-09-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
1
Registration Number
NCT00726830
Locations
🇺🇸

Palmetto Hematology Oncology, PC at Gibbs Regional Cancer Center, Spartanburg, South Carolina, United States

🇺🇸

M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States

Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain

First Posted Date
2008-05-28
Last Posted Date
2017-02-09
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
60
Registration Number
NCT00685295
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery

First Posted Date
2008-05-21
Last Posted Date
2012-01-06
Lead Sponsor
University of Parma
Target Recruit Count
22
Registration Number
NCT00681174
Locations
🇮🇹

University Hospital / Azienda Ospedaliero-Universitaria, Parma, PR, Italy

Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

Phase 2
Completed
Conditions
Interventions
First Posted Date
2008-03-18
Last Posted Date
2011-02-02
Lead Sponsor
Associazione Progetto Oncologia UMAN.A
Target Recruit Count
80
Registration Number
NCT00637975
Locations
🇮🇹

Ospedale Sacro Cuore, Negrar, Verona, Italy

🇮🇹

Ospedali Riuniti, Bergamo, Italy

🇮🇹

Ospedale S. Orsola, Brescia, Italy

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath